> The AstraZeneca vaccine looks not so good
This study, from Scotland, looks at risk of hospitalization after first dose of either Pfizer or AstraZeneca vaccine. The Pfizer and AstraZeneca vaccines look equally good. If anything, in the raw numbers AstraZeneca looks a little better that Pfizer, but the difference is well inside error bars.
https://www.bmj.com/content/372/bmj.n523
> especially against the South African variant
There is this one study, a proper randomized controlled trial from South Africa with 2000 people. But it only studies the AstraZeneca vaccine. They only saw mild (15 vaccine recipients and 17 placebo recipients) or moderate (4 vaccine recipients and 6 placebo recipients) infections, so they can not say anything about severe disease, because no one got it.
And they only studied AstraZeneca. Unfortunately, this study has been giving AstraZeneca maybe an undeservedly bad reputation, as media goes around saying that AstraZeneca specifically is not effective against the B.1.351 variant, suggesting that other vaccines would be. But as far as I know, similar studies of other vaccines do not exist, so we just don't know yet if they would be, maybe, equally bad against the B.1.351 variant or not.
https://www.nejm.org/doi/10.1056/NEJMoa2102214